Related Experiment Video
Updated: Feb 25, 2026
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
Current challenges in the accurate identification of Streptococcus pneumoniae and its serogroups/serotypes in the
Rosemol Varghese1, Ranjith Jayaraman1, Balaji Veeraraghavan1
1Department of Clinical Microbiology, Christian Medical College, Vellore, India.
Insights
Accurate identification of Streptococcus pneumoniae is crucial for estimating disease burden and guiding treatment, especially in developing nations. This review examines phenotypic and molecular methods for identifying S. pneumoniae and its serotypes, highlighting challenges in resource-limited settings.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Streptococcus pneumoniae causes significant pneumonia, meningitis, and invasive diseases in children globally.
- Accurate identification is hindered in developing countries by infrastructure, expertise, and procedural limitations.
- Current methods for S. pneumoniae identification and serotyping are often inconsistent, costly, or require specific expertise.
Purpose of the Study:
- To review the advantages and limitations of phenotypic tests for S. pneumoniae identification.
- To discuss the roles and challenges of molecular identification and serotyping methods for S. pneumoniae.
- To highlight the impact of diagnostic limitations on disease burden estimation and vaccine strategies.
Main Methods:
- Review of routinely used phenotypic identification tests for S. pneumoniae.
- Analysis of molecular techniques including PCR, real-time PCR, sequence analysis, PCR-RFLP, MALDI-TOF, MLST, MLSA, and WGS.
- Evaluation of challenges associated with these methods in developing countries.
Main Results:
- Phenotypic methods often lack sensitivity and specificity, delaying diagnosis.
- Molecular methods offer improved accuracy and speed but face implementation hurdles.
- Gold standard serotyping (Quellung) is resource-intensive and requires viable isolates.
- Inaccurate data on disease burden and serotype prevalence limits effective vaccine use.
Conclusions:
- Improved diagnostic strategies are essential for accurate S. pneumoniae disease burden estimation.
- Molecular methods show promise but require adaptation for resource-limited settings.
- Addressing diagnostic challenges is critical for optimizing pneumococcal disease prevention and control.
Abstract:
Streptococcus pneumoniae is a major cause of pneumonia, meningitis and other invasive diseases resulting in high mortality and morbidity among children under the age of five. Inaccurate identification of S. pneumoniae masks the exact estimation of disease burden and could delay treatment options. This is the common problem most frequently faced in developing countries due to several reasons that include poor infrastructure, insensitive operational procedures and lack of expertise. Inconsistent methods for phenotypic detection often delay the early identification and confirmation of S. pneumoniae. For serotyping S. pneumoniae, Quellung method is the gold standard which can be performed only on viable isolates, needs expertise and is expensive. Therefore, the data available on disease burden and serotype prevalence is not truly estimated in most of the developing countries, in turn, the use of available pneumococcal vaccines have been restricted. This current review deliberates an overview on advantages and limitations of routinely used phenotypic tests for S. pneumoniae identification. Also discussed in this review are the roles and current challenges faced by various molecular identification and serogroup/serotype identification methods of S. pneumoniae, including PCR, real time PCR, sequence analysis of different specific genes of S. pneumoniae, PCR combined with RFLP, MALDI-TOF, MLST, MLSA and WGS.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:28Methods of Classification and Identification
01:51Vaccinations